Zelluna Immunotherapy
Pre-clinicalOslo, Norwayzelluna.com
Zelluna is pioneering novel cell therapies for the treatment of cancer patients.
Founded
2016
Focus
BiologicsCell & Gene Therapy
About
Zelluna is pioneering novel cell therapies for the treatment of cancer patients.
Funding History
2Total raised: $26.5M
Series A$20MKorea Investment PartnersMar 15, 2023
Seed$6.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationOslo, Norway
StagePre-clinical
Contact
SIMILAR COMPANIES
Algipharma
Phase 1 · Bergen
Bio-Me
Pre-clinical · Oslo
CardiNor
Pre-clinical · Oslo
Gentian USA
Pre-clinical · Moss
Hemispherian
Phase 1 · Oslo
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile